Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Hair growth environment recreated with challenges; stem cells make successful skin organoids.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Terbinafine can cause hair loss.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Hair color is influenced by genetics and can indicate certain health conditions.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Cyclosporin doesn't stop hair loss.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.